In this study, exposure to genetically-influenced lower TG levels via APOA5 had additional beneficial effects on CAD risk on top of genetically-influenced lower TG levels via LPL and genetically-influenced lower LDL-C levels. This evidence concerns the gene LPL and coronary artery disorder.